Company Short-Term Debts: Regulus Therapeutics Inc. (RGLS)

Public company logo of Regulus (RGLS)

The Regulus Therapeutics (RGLS) price chart demonstrates the dynamics of a company whose RNA therapy developments remain independent of economic cycles or inflation. The current indicator stands at 0.00, while the business faces a liquidity shortage due to research and development costs. However, ownership of exclusive patents for kidney treatment guarantees long-term collaboration with major market players and regular payments.

RGLS - Regulus Therapeutics, Inc. Short-Term Indebtedness over the range 07/04/2022 - 07/05/2025

RGLS (Regulus): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart Regulus Therapeutics Inc.|RGLS - Fair Value Consensus
- market capitalization data:
Market Capitalization Regulus Therapeutics Inc.|RGLS - Total Enterprise Value
- book capitalization data:
Book Value per Share Regulus Therapeutics|RGLS - Book Value of Business|Market Cap to Net Assets Ratio regulusrx.com|RGLS - Company Total Assets
- debt and liquidity data:
Debt to Equity Regulus Therapeutics|RGLS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Regulus Therapeutics|RGLS - Company Aggregate Debts|Debt to Book Capitalization Ratio Regulus Therapeutics Inc.|RGLS - Long-Term Debt Volume|Company Current Liabilities Regulus Therapeutics
Fundamental company valuation:Regulus Therapeutics Inc. RGLS
Mass-produced product of regulusrx.com

This indicator consolidates all obligations with a maturity of up to one year, allowing for an assessment of liquidity risk and working capital management efficiency through the company's solvency. For Regulus Therapeutics (RGLS), controlling these borrowings is critical when financing the expansion of miRNA drugs and scaling RGLS8429 clinical trials, as clearly reflected in the history of short-term credits and loans.

Competitor analysis

Company Short-Term Debt Tempus AI, Inc (TEM)|QGEN - Company Short-Term Loans and Borrowings|Company Short-Term Debts IONS|Repligen Inc. (RGEN) - Short-Term Debt|Avidity Biosciences - Company Short-Term Debts|Short-Term Indebtedness crisprtx.com (CRSP)|Company Current Liabilities WGS|Company Short-Term Debts RARE (Ultragenyx Pharmaceutical Inc.)|Company Short-Term Debt Beam Therapeutics Corp BEAM|SRPT - Company Short-Term Debt|Twist Bioscience - Company Current Liabilities|TXG: Company Short-Term Debts|Intellia Therapeutics, Inc. - Company Short-Term Debt|Short-Term Debt Volume Stoke Therapeutics Inc|BLFS - Company Current Liabilities|Company Short-Term Loans and Borrowings Wave Pharma (WVE)|Company Current Liabilities Maze Therapeutics Inc|Amount of Current Liabilities sionnatx.com (SION)|Company Short-Term Debts Prime Medicine|Company Short-Term Loans and Borrowings Taysha Gene Therapies Inc TSHA|QURE (uniQure Corp) - Company Short-Term Debts|MGTX: Short-Term Debt|Company Short-Term Debt REGENXBIO Inc. RGNX|solidbio.com (SLDB) - Company Short-Term Loans and Borrowings|OCGN (Ocugen) - Company Short-Term Debts|Company Short-Term Debts PACB|BNTC - Company Short-Term Debt|Current Liabilities Design Corp (DSGN)|RCKT: Company Short-Term Debts|FDMT - Short-Term Debt|Lexeo - Company Current Liabilities|Korro Bio, Inc. (KRRO) - Company Short-Term Debts|EDIT - Company Current Liabilities|Silence Therapeutics Corp (SLN) - Amount of Current Liabilities|PRQR: Company Short-Term Debts|Short-Term Debt Volume Codexis Bio|Company Short-Term Debts SGMO (Sangamo Therapeutics, Inc.)|Company Current Liabilities NAUT (nautilus.bio)|Company Short-Term Debt MGX|precisionbiosciences.com - Short-Term Debt Volume|Company Short-Term Debt Generation Bio Corp (GBIO)|BOLD - Company Short-Term Loans and Borrowings|Company Short-Term Debts XCUR (exicuretx.com)|IMNN (Imunon) - Short-Term Indebtedness|Company Short-Term Debt Phio Pharmaceuticals Corp|Company Short-Term Debt MBIO|RNAZ (TransCode Therapeutics) - Company Short-Term Debt|Short-Term Debt Volume bionanogenomics.com (BNGO)|APDN - Company Short-Term Debts|bluebird bio Inc. - Company Short-Term Indebtedness|ImmunoPrecise (IPA) - Company Short-Term Debt|OMGA - Company Short-Term Indebtedness|OMIC: Company Short-Term Debts|SYRS (syros.com) - Company Short-Term Debts|TBIO - Company Short-Term Debt|Company Short-Term Loans and Borrowings TRACON Pharmaceuticals Inc.|Unity Bio - Company Short-Term Debts